The influence of physicians' guideline compliance on patients' statin adherence: A retrospective cohort study
References (52)
- et al.
Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins
Am J Cardiol
(2004) - et al.
Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice
Am J Med
(2002) - et al.
Effectiveness of antihyperlipidemic drug management in clinical practice
Clin Ther
(1999) - et al.
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpa tients with polypharmacy
Am J Med
(1996) - et al.
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
J Am Coll Cardiol
(2002) - et al.
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
J Clin Epidemiol
(1997) Treating dyslipidemia with statins: The riskbenefit profile
Am Heart J
(2003)- et al.
Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment
Patient Educ Couns
(2000) Resource management in prevention of coronary heart disease: Optimising prescription of lipid-lowering drugs
Lancet
(2002)- et al.
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Circulation
(2004)
Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment
Ann Behav Med
Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, andcoronary artery disease
N Engl J Med
MRC/ BHF Heart Protection Study of cholesterol loweringwith simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
Lancet
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
Lancet
Metaanalysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes
Br J Clin Pharmacol
Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines
J Gen Intern Med
Use and monitoring of “statin” lipid-lowering drugs compared with guidelines
Arch Intern Med
Long-term persistence in use of statin therapy in elderly patients
JAMA
Persistence of use of lipid-lowering medications: A cross-national study
JAMA
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
JAMA
The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
Arch Intern Med
Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease
Arch Intern Med
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
JAMA
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations
J Gen Intern Med
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals
Am J Med
Impact of medication adherence on hospitalization risk and healthcare cost
Med Care
Cited by (21)
A Risk Model to Predict Statin Non-Adherence Following an Acute Coronary Syndrome
2023, Heart Lung and CirculationMedication oversupply in patients with diabetes
2015, Research in Social and Administrative PharmacyCitation Excerpt :This is notably less than reported in prior studies of Veterans,22,39,41 Medicaid enrollees,42 and other underserved patients receiving care in safety-net systems,14–16 where oversupply was observed in ∼25–50% of patients taking these classes. The lower prevalence of oversupply observed in this study of 2006–2008 claims, compared to past studies using older data (i.e., 1990s and early 2000s),14–16,22,39,41,42 may reflect payers' increased use in recent years of computerized utilization management systems designed to prevent dispensing of oversupplies. Such computerized systems identify early refills and duplicate prescriptions within a subclass when patients attempt to obtain them at pharmacies.
Cholesterol treatment and changes in guidelines in an academic medical practice
2015, American Journal of MedicineAccess to heart failure care post emergency department visit: Do we meet established benchmarks and does it matter?
2013, American Heart JournalCitation Excerpt :In our study, the adherence to the recommended 2-week timeline for consultation subsequent to an ED visit was 30.2%. This is lower than the 39% adherence rate with respect to a guideline of 8-week follow-up of patients who were newly prescribed statin therapy.27 The authors of this latter study suggest that the low adherence to this guideline stems from difficulty to schedule patients within the “short” timeframe of 8 weeks.
Prevention and Treatment. A Tale of Two Strategies<sup>*</sup>*Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
2008, Journal of the American College of CardiologyThe Things to Come of SHAPE: Cost and Effectiveness of Cardiovascular Prevention
2007, American Journal of Cardiology